Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Business Exposures
Activism
Animal Testing
Artificial Intelligence
Boeing 737
Brexit
Cannabis
Censorship
Climate
Coal
COVID-19
Criminal
Death
Debt Markets
Derivatives
Diversity
Economy
Electric Vehicles
Electricity Generation
Ethanol
Financial
Firearms
Fossil Fuels
Glyphosate
Harassement
Immigration
Information Security
Intellectual Property
Interest Rates
Labor
Layoff
Lead
Legal
Palm Oil
Pension
Political
Product Safety
Regulatory
Religion
Securities Market
Supply Chain
Tariff
Textiles
US Equities
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Beta Bionics BBNX Q1 2026 Earnings Transcript
↗
April 21, 2026
Via
The Motley Fool
Tickers
BBNX
Exposures
Product Safety
Stock Market Today, April 21: Hims & Hers Health Drops as Amazon Unveils Competing Weight Loss Program
↗
April 21, 2026
Via
The Motley Fool
Topics
Stocks
Tickers
AMZN
HIMS
NVO
Exposures
Product Safety
US Equities
Kopp Family Office Trims $3.5 Million Worth of Viridian Therapeutics Stake -- What Investors Should Know
↗
April 21, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
Tickers
VRDN
Exposures
Legal
Product Safety
Regulatory
Presidential Executive Order to Accelerate Approval of Psychedelic Medications; Those Being Developed by NRx Pharmaceuticals, Inc. (Nasdaq: NRXP)
April 21, 2026
Via
Get News
Topics
Government
Tickers
NRXP
Exposures
Political
Product Safety
What Should Users Know When Bulk Purchasing Plastic Bottle
April 21, 2026
Via
AB Newswire
Topics
Product Recall
Exposures
Legal
Product Safety
Agios (AGIO) Q2 2025 Earnings Call Transcript
↗
April 21, 2026
Via
The Motley Fool
Topics
Earnings
Tickers
AGIO
Exposures
Financial
Product Safety
Urban Edge (UE) Q2 2025 Earnings Transcript
↗
April 21, 2026
Via
The Motley Fool
Tickers
UE
Exposures
Product Safety
Presidential Acceleration of Psychedelic Therapies Enters a Defining Moment as Federal Policy, FDA Alignment & Breakthrough Neurotechnology Converge
April 21, 2026
Via
PRLog
Exposures
Product Safety
Agios (AGIO) Q3 2025 Earnings Transcript
↗
April 21, 2026
Via
The Motley Fool
Tickers
AGIO
Exposures
Product Safety
BXMT Q2 2025 Earnings Call Transcript
↗
April 21, 2026
Via
The Motley Fool
Topics
Earnings
Tickers
BXMT
Exposures
Financial
Product Safety
BioMedNewsBreaks — NanoViricides (NYSE American: NNVC) Highlights NV-387 as Potential Measles Treatment
April 21, 2026
Via
Investor Brand Network
Tickers
NNVC
Exposures
COVID-19
Product Safety
Ionis (IONS) Q4 2025 Earnings Transcript
↗
April 21, 2026
Via
The Motley Fool
Tickers
IONS
Exposures
Product Safety
Federal Court Reportedly Halts Kennedy's Vaccine Panel, Putting COVID, Flu And RSV Shots At Risk
↗
April 21, 2026
Via
Benzinga
Exposures
COVID-19
Product Safety
PharmaTher Highlights Strategic Ketamine Opportunity Following New U.S. Executive Order on Psychedelic Treatments for Serious Mental Illness
April 21, 2026
Via
Newsfile
Tickers
CSE:PHRM
PHRRF
Exposures
Product Safety
A Monthly Weight Loss Shot? Why Pfizer Could Topple Lilly's and Novo's GLP-1 Duopoly
↗
April 21, 2026
Via
The Motley Fool
Tickers
ABBV
HIMS
LLY
NVO
PFE
Exposures
Product Safety
Top Wall Street Forecasters Revamp Intuitive Surgical Expectations Ahead Of Q1 Earnings
↗
April 21, 2026
Via
Benzinga
Exposures
Product Safety
Non-Pharmaceutical Knee Pain Treatment With StemWave Announced, DuBois PA
April 21, 2026
Via
Press Release Distribution Service
Exposures
Product Safety
Deadline Approaching for Investors of ImmunityBio, Inc. (NASDAQ: IBRX) - Contact Kaplan Fox Before May 26, 2026
April 20, 2026
Via
NewMediaWire
Topics
Lawsuit
Tickers
IBRX
Exposures
Financial
Legal
Product Safety
Deadline Approaching for Investors of ImmunityBio, Inc. (NASDAQ: IBRX) - Contact Kaplan Fox Before May 26, 2026
April 20, 2026
Via
TheNewswire.com
Topics
Lawsuit
Tickers
IBRX
Exposures
Financial
Legal
Product Safety
Ibogaine by David Dardashti Aligns with New Federal”Right to Try” Directives to Target the NeurologicalRoots of Childhood Trauma
April 20, 2026
Via
AB Newswire
Exposures
Product Safety
Save This Psychedelic Stock Watchlist After Trump’s Latest Executive Order
April 20, 2026
Via
Barchart.com
Topics
Cannabis
ETFs
Government
Exposures
Cannabis
Political
Product Safety
Trump Sends Compass Pathways Stock Soaring as He Backs Psychedelics. Should You Buy CMPS Here?
April 20, 2026
Via
Barchart.com
Topics
Government
Exposures
Political
Product Safety
AMATORUS WOUND GUARD Passes all Antimicrobial Efficacy Testing
April 20, 2026
Via
Get News
Tickers
AAPL
Exposures
Product Safety
Here's Why Agios Pharmaceuticals Crashed 23% Today
↗
April 20, 2026
Via
The Motley Fool
Tickers
AGIO
NVO
Exposures
Product Safety
Why Compass Pathways Stock Rocketed 40% Today
↗
April 20, 2026
Via
The Motley Fool
Topics
Government
Tickers
CMPS
MMM
Exposures
Political
Product Safety
What's Pushing Moderna Stock Higher Today?
↗
April 20, 2026
Via
Benzinga
Tickers
MRNA
Exposures
Product Safety
PsychedelicNewsBreaks – Helus Pharma(TM) (NASDAQ: HELP) (Cboe CA: HELP) Supports Executive Order Advancing Psychedelic Therapies
April 20, 2026
Via
Investor Brand Network
Tickers
HELP
Exposures
Product Safety
Trump Just Fast-Tracked Psychedelic Treatments: 3 Under-the-Radar Stocks That Could Be About to Soar
↗
April 20, 2026
Via
The Motley Fool
Topics
Government
Tickers
ATAI
CMPS
DFTX
MMM
Exposures
Political
Product Safety
BioMedNewsBreaks — Lantern Pharma (NASDAQ: LTRN) Schedules FDA Type C Meeting For HARMONIC Trial Amendments
April 20, 2026
Via
Investor Brand Network
Topics
Artificial Intelligence
Tickers
LTRN
Exposures
Artificial Intelligence
Product Safety
BioMedNewsBreaks — NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Supports Executive Order To Accelerate Psychedelic Drug Development
April 20, 2026
Via
Investor Brand Network
Tickers
BMWYY
NRXP
Exposures
Product Safety
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.